drugset / Trial / NCT04000919

Effects of 5HTP and LDOPA on CNS Excitability After SCI

NCT04000919

Phase 2/3 Suspended 30 enrolled Jessica M D'Amico
RandomizedCrossoverDouble-blindBasic science

Summary

This study will examine whether supplementation with the serotonin and dopamine precursors, 5HTP and L-DOPA can alter central nervous system excitability and improve motor function after incomplete and complete spinal cord injuries.

Timeline

Start
2019-06-19
Primary completion
2023-06-30
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator 5HTP Other / unclassified 50 mg
Comparator 5HTP Other / unclassified 200 mg
Comparator Carbidopa Unknown 50 mg
Comparator Levodopa Small molecule 50 mg
Comparator Levodopa Small molecule 200 mg

Indications